Author

Elizabeth B. Perry

Yale UniversityORCID 0000-0002-5509-4628Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

Jeffrey P. TownsendiD· 2 shared Alexander YangiD· 1 shared Ansley M. RocheiD· 1 shared Barbara Ann BurtnessiD· 1 shared Benjamin Schiff· 1 shared Christopher N. CrossiD· 1 shared Cindy YangiD· 1 shared Dejian ZhaoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jeffrey P. TownsendORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 25, 2025

Somatic evolution of prostate cancer: mutation, selection, and epistasis across disease stages

Moein Rajaei, Alexander Yang, Kira A. Glasmacher…·Jeffrey P. Townsend

This study quantifies mutation rates, selection coefficients, and epistatic interactions across prostate cancer stages, revealing dynamic selective pressures and therapeutic implications.

DOI 10.1101/2025.09.25.678387

humanwhole-exome sequencing

Cancer BiologybioRxivPreprintMay 28, 2025

AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancers

Jong Woo Lee, Jackie Shi, Julian Barrantes…·Barbara Ann Burtness

This study shows that AURKA inhibition increases DNA replication stress in TP53-mutated cancers, creating a dependency on WEE1 that can be exploited with combined AURKA and WEE1 inhibition to enhance antitumor effects.

DOI 10.1101/2025.05.28.656693

humanexperimental assay